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CASE REPORT
Cladophialophora carrionii: A RARE AGENT OF CHROMOBLASTOMYCOSIS IN  
RIO DE JANEIRO STATE, BRAZIL
Marcelle de F. MOUCHALOUAT, Maria Clara G. GALHARDO, Paulo Cezar Monteiro FIALHO, Janice Mery C. de Oliveira COELHO,  
Rosely Maria ZANCOPÉ-OLIVEIRA & Antonio Carlos F. do VALLE
SUMMARY
A 73 year-old male farm laborer from a rural area presented a 15 year history of extensive tumoral lesions over his left leg. 
Histological studies of skin biopsy showed pseudoepitheliomatous hyperplasia and granulomatous chronic inflammatory process 
with muriform cells, confirming chromoblastomycosis (CBM). Cladophialophora carrionii was isolated in culture. Treatment with 
itraconazole 400 mg/day for 12 months resulted in complete remission of lesions. As far we aware, this is the first case report of CBM 
caused by Cladophialophora carrionii in Rio de Janeiro State, Brazil.
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INTRODUCTION
 
Chromoblastomycosis (CBM) is a chronic disease of cutaneous and 
subcutaneous tissues caused by filamentous fungi of the dematiaceae 
family (with melanic-type pigment in the wall).
Most cases have been described in tropical and subtropical regions, 
especially in Madagascar, Brazil, Japan, Venezuela and México25. Most 
infections are caused by Fonsecaea pedrosoi. C. carrionii is the second 
most common agent, presenting in dry areas with a dry climate, such 
as spiny desert in southern deciduous thicket ecosystem in Madagascar 
and Venezuela12,17,25. 
Pará State is the major focus of CBM in Brazil, with F. pedrosoi, 
which is the most common agent followed by Phialophora verrucosa. 
According to Medline, Lilacs and Scielo databases, C. carrionii has not 
been described as agent of this mycosis. We report the first case of CBM 
caused by C. carrionii in Rio de Janeiro State, Brazil.
CASE REPORT
A 73-year-old male, farm laborer, living in Itaboraí, a rural city 45 
km far from city of Rio de Janeiro, presenting painful lesions over his 
left leg for 15 years was referred to the outpatient clinic of infectious 
dermatology (IPEC - Fiocruz). The patient denied other problems, such 
as diabetes and hypertensive disease but was in poor health and nutritional 
conditions. He has never been outside Rio de Janeiro State.
Lesions were erythematous to violaceous papules, painfull, in 
different sizes, forming tumoral lesions with irregular bleeding on the 
surface, the largest one measuring 8 x 6 cm (Fig. 1). Myiasis and edema 
of the affected leg were present. Local lymph nodes were not involved. 
X-ray indicated no bone involvement.
Hematoxylin and eosin stained sections of biopsy material showed 
pseudoepitheliomatous hyperplasia and granulomatous chronic 
inflammatory process with multinucleate giant cells, epithelioid cells, 
histiocytes, lymphocytes and neutrophils inside microabscesses. There 
were muriform cells within and outside the multinucleate giant cells. 
Additionally special stains PAS and Grocott were performed.
KOH preparation was negative. Culture on Sabouraud 2% glucose 
agar yielded velvety olive-black colony within four weeks. Microscopic 
slide examination of culture material on potato glucose agar revealed 
acropetal conidia pale olivaceous, limoniform, arising in long branched 
chains, smooth-walled or slightly verrucose suggestive of C. carrionii 
(Fig. 2). Additionally the agent was identified by molecular sequence 
data of the ITS1-ITS2 regions of the rDNA. The sequence matched C. 
carrionii in GenBank (www.ncbi.nlm.nih.gov/genebank).
The patient was initially treated with ivermectin and cephalexin for 
secondary infection. Itraconazole 200 mg twice a day was administered 
for 12 months with good response. 
No adverse effects were noted. Atrophic scars formed in healed 
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areas. Mycological examination was negative and histopathology showed 
inflammatory process with lymphocytes and cicatricial fibrosis. Relapse 
was not reported in two years of follow-up after cure.
DISCUSSION
In Brazil, there is scant information concerning the incidence of CBM, 
as it is not a reportable condition. This mycosis has been reported in states 
of Pará23, Rio Grande do Sul11, Paraná18, Maranhão22, Rio de Janeiro15, 
Pernambuco10, Mato Grosso21, Rondônia1, Ceará14. These studies show 
that in CBM predominate sex male, farm laborer, presenting verrucous 
form located in lower limb with long course of disease (more than ten 
years). As a whole, F. pedrosoi and P. verrucosa are the most common 
agents23. Other identified CBM agents are F. compacta, Exophiala 
jeanselmei, E. castellanii, and Rhinocladiella aquaspersa11,13,18,24.
C. carrionii is ubiquitous in the semi-arid area, where xerophytes 
are found, predominantly Cactaceae, possibly a natural reservoir of the 
fungus7. The name Cladophialophora is used instead of Cladosporium 
because of its ability to produce phialides6. Surprisingly, the patient was 
living in Itaboraí, a place of tropical climate, temperature range 12 - 33 
°C (average 18 °C) and annual rainfall 1,000-1,500 mm/year, differing 
considerably from areas where C. carrionii is found and never went to 
another place. There are only two cases of CBM caused by C. carrionii 
in Brazil, in states of Pernambuco and Pará10,16. In Pernambuco State, 
from nine cases of CBM, only one patient had a disease caused by C. 
carrionii, presenting desquamative plaques in lower limbs with ten 
years of evolution. In Pará, a case of CBM was reported, caused by this 
agent and lobomycosis with the same lesions as the farm laborer who 
presented verrucous and nodular forms in lower limb with 18 years of 
course of disease.
The present patient was an agricultural worker as it is typically found 
for CBM23. Median incubation period for CBM is not known; however, 
most cases progress slowly, e.g. 15 years like this case, over many years 
and sometimes decades. 
The patient presented tumoral lesions, but the clinical aspect of the 
lesions is diverse; verrucous is the most frequently reported lesion, and 
most lesions are present on the lower limbs11,12,23. 
In this study, rRNA gene ITS region was amplified and sequenced. 
Identification based on molecular sequence with high sensitivity provide 
an additional way to characterize and identify molecularly the etiologic 
agents of CBM5.
In CBM, the clinical aspect is not related to the agent. However 
different therapeutic reactions can be obtained according to the agent. 
Itraconazole, is the drug of choice for CBM and seems to be the best 
therapy for C. carrionii, that presents better response to antifungal agents 
than F. pedrosoi2,20. Our patient showed good response, with cure in 12 
months of treatment, in spite of the severe form of the disease19. Treatment 
should be continued until clinical resolution; which usually occurs after 
several months of therapy3. Relapse is common, however, especially in 
the most extensive lesions12. Terbinafine, cryotherapy and surgery are 
other options of treatment4,9,26. Recently, terbinafine and itraconazole 
were used with good results9.
RESUMO
Cladophialophora carrionii: agente raro de cromoblastomicose no 
estado do Rio de Janeiro, Brasil.
Lavrador, com 73 anos, residente em área rural apresentava há 15 anos 
lesões tumorais disseminadas na perna esquerda. Exame histopatológico 
de biópsia de pele mostrou hiperplasia pseudo-epiteliomatosa e processo 
inflamatório crônico granulomatoso com células muriformes, confirmando 
o diagnóstico de cromoblastomicose (CBM). Cladophialophora carrionii 
foi isolado na cultura. Tratamento com itraconazol 400 mg/dia durante 12 
meses resultou na completa remissão das lesões. Este é o primeiro relato 
de CBM causado por C. carrionii no estado do Rio de Janeiro, Brasil.
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Fig. 2 - C. carrionii: long, flexuous, branching chains of conidia that are regular in size 
(slide culture).
Fig 1 - Extensive tumoral lesions.
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